Qiagen NV reported $20M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
argenx SE USD 44.87M 2.17M Dec/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 10M 1000K Mar/2026
Moderna USD 70M 3M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Revvity USD 5.75M 5.75M Dec/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025